
Conversations in Cancer: Presentations on leading research at the BC Cancer Agency and a workshop to foster cross-disciplinary interactions
| Time | Topic | Details |
| 08:15 - 09:30 | Light Breakfast - Bayshore Ballroom Salon ABC | |
| 09:30 - 09:45 | Arsenic Related Lung Cancer: a growing problem for the world | Victor Martinez |
| 09:45 - 10:00 | Late Morbidity Leading to Hospitalization Among 5-yr Survivors of Young Adult Cancer | Yang Zhang |
| 10:00 - 10:15 | Resource Utilization And Costs Associated With The Early Detection Of Lung Cancer: The Pan-Canadian Experience | Sonya Cressman |
| 10:15 - 10:30 | Coffee Break | |
| 10:30 - 10:45 | Combining Virtual And High-Throughput Screening To Reposition Existing Drugs For Triple Negative Breast Cancer | Yvonne Li |
| 10:45 - 11:00 | Development of Personalized Vaccines Targeting Tumour-Specific Mutations | Spencer Martin |
| 11:00 - 11:15 | Exploring Mutational Evolution In Metastatic Colorectal Cancer | Jill Mwenifumbo |
| 11:15 - 11:30 | Narrow Time Window Between Tumor Resection To Regional Failure: Can we salvage the necks and lives? | Yi-Ping Liu |
| 11:30 - 11:45 | Understanding the Adoption of Fluorescence Visualization by Head and Neck Surgeons: Preparation for knowledge translation in the COOLS trial | Sarah Gustin |
| 11:45 - 12:00 | A Screen for New Cancer Specific Drugs That Target Centrosome Clustering | Eiko Kawamura |
| 12:00 - 13:00 | Lunch and Networking- Bayshore Ballroom Salon ABC | |
The objectives of the event: to bring together TFRI researchers and share information and ideas about current and future activities and directions for translational research in the challenging area of variation (heterogeneity) of patient outcomes.
| Time | Topic | Details |
| 13:00 - 13:10 | Welcome and Introductory Remarks from Hosts | |
| 13:10 - 14:00 | Keynote Presentation | Nadine Caron |
| 14:00 - 14:12 | Amelioration of Irinotecan Induced Gastrointestinal Toxicity in Sprague-Dawley Rats by Use of Ininophore C™, a Nanoparticle Formation of Irinotecan Project: Clinical Translation of Novel Anti-Cancer Agent Irinophore C as a Treatment for Colorectal Cancer |
Dawn Waterhouse |
| 14:12 - 14:24 | Recurrent Somatic DICER1 Mutations in Non-epithelial Ovarian Cancers Project: The Terry Fox New Frontiers Program Project in Genomics of Forme Fruste Tumours: New vistas on cancer biology and management |
|
| 14:24 - 14:36 | Shining the Light from Bench to Bedside for Early Stage Oral Cancer Control – the COOLS Trial Project: COOLS (Canadian Optically Guided Approach for Oral Lesions Surgical) |
|
| 14:36 - 14:48 | Advancing the Promise of Personalized Oncology Using Massively Parallel Sequencing Combined with Computer Science and Patient Derived Xenografts Project: Canadian Prostate Cancer Biomarker Network (Phase I) |
Colin Collins |
| 14:48 - 15:00 | Defining the Role of Lyn Kinase in Prostate Cancer Progression to Castrate Resistance Stage Project: Defining the Role of Lyn Kinase in Prostate Cancer Progression to Castrate Resistance Stage |
Amina Zoubeidi |
| 15:00 - 15:12 | Functional Genomics of Yeast Genome Integrity Identifies R-loop Mediated Chromosome Instability in mRNA Cleavage and Polyadenylation Mutants Project: Cataloguing Chromosome Instability Mutants: Implications for cell biology, cancer and therapeutic design |
Peter C. Stirling |
| 15:12 - 15:24 | A Comprehensive Genome-Wide Characterization of Meis1 Induced Leukemic Transformation Project: Cell Fate Control of Normal and Malignant Stem Cells |
Eric Yung |
| 15:24 - 15:36 | Hypoxic Tumour Cells Induce Myeloid-Derived Suppressor Cell Accumulation in Metastatic Target Organs Project: Promotion of Metastasis by Bone Marrow-Derived Cells |
Kevin Bennewith |
| 15:36 - 16:00 | Refreshment Break | |
| 16:00 - 16:12 | Identification of Sister Chromatids by their DNA Template Strands Project: The Terry Fox New Frontiers Program Project in Genomics of Forme Fruste Tumours: New vistas on cancer biology and management |
Peter Lansdorp |
| 16:12 - 16:24 | Identification of Differentially Expressed Circulating MicroRNAs in the Serum of Patients with Lung Adenocarcinoma Project: Circulating MicroRNAs as a Lung Tumour Proxy: Determining whether a small RNA species in plasma can be used as an early cancer detection tool |
Sara McLellan |
| 16:24 - 16:36 | The Pan-Canadian Early Detection of Lung Cancer Study Project: Early Detection of Lung Cancer - A pan-Canadian study |
Stephen Lam |
| 16:36 - 16:48 | Surgical Margins Assessment Using Molecular and Phenotypic Alterations Associated with Risk in a Trial of Fluorescence-Guided Surgery – The COOLS trial Project: COOLS (Canadian Optically Guided Approach for Oral Lesions Surgical) |
Miriam Rosin |
| 16:48 - 17:00 | Role of SASH1 in LPS-Induced Sepsis Project: Improved Assignment to Best Available Therapy for Myelodysplasia / Acute Myeloid Leukemia |
Angela Hussainkhel |
| 17:00 - 17:12 | High-Mobility Group A2 (Hmga2) Overexpression in Adult Murine Hematopoietic Stem Cells Activates Fetal Properties Project: Cell Fate Control of Normal and Malignant Stem Cells |
Michael Copley |
| 17:12 - 17:24 | Biology of Cancer: Insights from genomic analyses of lymphoid neoplasms Project: Biology of cancer: Insights from genomic analyses of lymphoid neoplasms |
|
| 17:24 - 17:36 | B-cells with High Side Scatter Parameter by Flow Cytometry Correlate with Inferior Survival in Diffuse Large B Cell Lymphoma Project: Flow Informatics Approaches for the Identification of Normal and Malignant Stem Cells |
Ali Bashashati |
| 17:36 - 17:48 | TBD | TBD |
| 17:48 - 18:00 | Closing Remarks | Marco Marra |
| 18:00 - 20:00 | Poster Session | With Appetizers and Cash Bar |